Mindful Self-Compassion for Breast Cancer Survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm, randomized controlled trial enrolling 80 breast cancer survivors who completed primary treatment within the past 12 months. Participants are assigned to either Mindful Self-Compassion (MSC) plus usual care or usual care with a waitlist control, in two cohorts of 40. The trial will explore whether MSC improves factors such as posttraumatic growth and emotional distress, and whether changes in self-compassion and emotional processing explain any benefits. Mechanisms under study include rumination, cognitive reappraisal, expressive suppression, and experiential avoidance. Outcomes are measured at baseline, after the program, and at a three-month follow-up.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 20 years or older.
* Physician-diagnosed breast cancer and completion of the primary treatment required for the individual's condition within the 12 months before enrollment. Treatment may include surgery, chemotherapy, or radiotherapy; completion of all treatment types is not required.
* No known distant metastasis at enrollment and no other newly diagnosed cancer since the initial breast cancer diagnosis.
* Aware of the breast cancer diagnosis and able to understand the study information and provide informed consent independently.
* Able to participate in group sessions and complete questionnaires in the language used in the study, and willing to complete baseline, post-program, and three-month follow-up assessments.

Exclusion Criteria:

* Significant cognitive, hearing, or communication difficulties that prevent understanding the study or participating in the program despite appropriate assistance.
* Current acute psychiatric symptoms or another unstable physical or psychological condition that makes group participation unsuitable on clinical assessment.
* Acute risk of self-harm or suicide requiring priority intervention.

Where it's running

• Cheng Ching General Hospital
  Taichung, Taiwan Recruiting
• Department of Psychology, Chung Yuan Christian University
  Taoyuan City, Taiwan Recruiting

Study contacts

• Principal investigator: Pei-Chiung Tu, PhD — Chung Yuan Christian University
• Study coordinator: Pei-Chiung Tu, PhD
• Email: ihpsolab@gmail.com
• Phone: +886-935220414

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.